{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:53Z","timestamp":1786118753148,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/cad.0b013e3280147d13","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T03:50:38Z","timestamp":1174535438000},"page":"569-579","source":"Crossref","is-referenced-by-count":25,"title":["Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model"],"prefix":"10.1097","volume":"18","author":[{"given":"Claudius","family":"Conrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Ischenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"K\u00f6hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Guba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Yezhelyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Barge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Wedge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Walter","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane J.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00001622-199807000-00014","article-title":"Pancreatic cancer","volume":"10","author":"Brand","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJM199202133260706","article-title":"Pancreatic carcinoma","volume":"326","author":"Warshaw","year":"1992","journal-title":"N Engl J Med"},{"issue":"(Suppl 1)","key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0959-8049(96)00324-3","article-title":"Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil","volume":"33","author":"Burris","year":"1997","journal-title":"Eur J Cancer"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/oxfordjournals.annonc.a010600","article-title":"A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer","volume":"7","author":"Rothenberg","year":"1996","journal-title":"Ann Oncol"},{"key":"R6-7-20210203","first-page":"3964","article-title":"Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer","volume":"55","author":"Takahashi","year":"1995","journal-title":"Cancer Res"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1073\/pnas.84.21.7567","article-title":"Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle","volume":"84","author":"Smith","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-7-20210203","first-page":"3959","article-title":"Induction and expression of amphiregulin in human pancreatic cancer","volume":"54","author":"Ebert","year":"1994","journal-title":"Cancer Res"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1006\/bbrc.1994.2131","article-title":"Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer","volume":"202","author":"Kobrin","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI116001","article-title":"Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha","volume":"90","author":"Korc","year":"1992","journal-title":"J Clin Invest"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/(SICI)1097-0215(19961211)68:6<782::AID-IJC16>3.0.CO;2-2","article-title":"Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum","volume":"68","author":"Wagner","year":"1996","journal-title":"Int J Cancer"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"R13-7-20210203","first-page":"257","article-title":"Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice","volume":"5","author":"Perrotte","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/S0959-8049(96)00396-6","article-title":"Reciprocal paracrine interactions between tumour cells and endothelial cells: the \u2018angiogenesis progression\u2019 hypothesis","volume":"32A","author":"Rak","year":"1996","journal-title":"Eur J Cancer"},{"key":"R15-7-20210203","first-page":"1523","article-title":"Neutralizing antibodies against epidermal growth factor and ErbB-2\/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors","volume":"151","author":"Petit","year":"1997","journal-title":"Am J Pathol"},{"key":"R16-7-20210203","first-page":"4645","article-title":"ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration","volume":"62","author":"Wedge","year":"2002","journal-title":"Cancer Res"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.neo.7900005","article-title":"In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice","volume":"1","author":"Bruns","year":"1999","journal-title":"Neoplasia"},{"key":"R18-7-20210203","first-page":"5575","article-title":"A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis","volume":"61","author":"Guba","year":"2001","journal-title":"Cancer Res"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"R21-7-20210203","first-page":"5822","article-title":"Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis","volume":"53","author":"Plate","year":"1993","journal-title":"Cancer Res"},{"key":"R22-7-20210203","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","article-title":"High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis","volume":"72","author":"Millauer","year":"1993","journal-title":"Cell"},{"key":"R23-7-20210203","first-page":"301","article-title":"Spatial and temporal expression of angiogenic molecules during tumor growth and progression","volume":"10","author":"Kumar","year":"1998","journal-title":"Oncol Res"},{"key":"R24-7-20210203","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/S0959-8049(96)00389-9","article-title":"Angiogenesis and metastasis","volume":"32A","author":"Ellis","year":"1996","journal-title":"Eur J Cancer"},{"issue":"(Suppl 3)","key":"R25-7-20210203","first-page":"225","article-title":"Critical determinants of neoplastic angiogenesis","volume":"6","author":"Fidler","year":"2000","journal-title":"Cancer J"},{"key":"R26-7-20210203","first-page":"4593","article-title":"Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders","volume":"57","author":"Presta","year":"1997","journal-title":"Cancer Res"},{"key":"R27-7-20210203","first-page":"49","article-title":"Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor","volume":"9","author":"Lin","year":"1998","journal-title":"Cell Growth Differ"},{"key":"R28-7-20210203","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1073\/pnas.93.16.8502","article-title":"Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor","volume":"93","author":"Cheng","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-7-20210203","first-page":"1324","article-title":"Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR\/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo","volume":"56","author":"Ramakrishnan","year":"1996","journal-title":"Cancer Res"},{"key":"R30-7-20210203","first-page":"1615","article-title":"Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo","volume":"56","author":"Millauer","year":"1996","journal-title":"Cancer Res"},{"key":"R31-7-20210203","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.bjc.6690248","article-title":"Prognostic significance of angiogenesis in human pancreatic cancer","volume":"79","author":"Ikeda","year":"1999","journal-title":"Br J Cancer"},{"key":"R32-7-20210203","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/1097-0142(20000801)89:3<488::AID-CNCR3>3.0.CO;2-X","article-title":"Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases","volume":"9","author":"Bruns","year":"2000","journal-title":"Cancer"},{"key":"R33-7-20210203","first-page":"2926","article-title":"Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma","volume":"60","author":"Bruns","year":"2000","journal-title":"Cancer Res"},{"key":"R34-7-20210203","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/108497801753354267","article-title":"Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787\/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases","volume":"16","author":"Solorzano","year":"2001","journal-title":"Cancer Biother Radiopharm"},{"key":"R35-7-20210203","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2005.11.005","article-title":"ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells","volume":"71","author":"Giannelli","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"R36-7-20210203","first-page":"1051","article-title":"ZD6474, a small molecule targeting VEGF and EGF receptor signaling, inhibits lung angiogenesis and metastasis and improves survival in an orthotopic model of non-small cell lung cancer","volume":"45","author":"Wu","year":"2004","journal-title":"Proc Am Assoc Cancer Res"},{"key":"R37-7-20210203","first-page":"9","article-title":"ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase activity, inhibits growth of human non-small cell lung cancer metastases that are resistant to treatment with ZD1839","volume":"44","author":"Matsumori","year":"2003","journal-title":"Proc Am Assoc Cancer Res"},{"key":"R38-7-20210203","first-page":"1130","article-title":"ZD6474 prevents the formation of ductal hyperplasia, carcinoma in situ, and invasive tumors in the DMBA model of rat mammary carcinogenesis","volume":"44","author":"Heffelfinger","year":"2003","journal-title":"Proc Am Assoc Cancer Res"},{"key":"R40-7-20210203","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/1078-0432.CCR-1100-03","article-title":"Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy","volume":"10","author":"Ciardiello","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R41-7-20210203","first-page":"205","article-title":"Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs","volume":"22","author":"Ciardiello","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R42-7-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.10681","article-title":"Effect of the VEGF-R2 antibody, DC101,+Gemcitabine on growth, metastasis, and angiogenesis of human pancreatic cancer growing orthotopically in nude mice","volume":"102","author":"Bruns","year":"2002","journal-title":"Int J Cancer"},{"key":"R43-7-20210203","first-page":"1996","article-title":"Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer","volume":"62","author":"Baker","year":"2002","journal-title":"Cancer Res"},{"key":"R44-7-20210203","first-page":"2178","article-title":"PTK787\/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration","volume":"60","author":"Wood","year":"2000","journal-title":"Cancer Res"},{"key":"R45-7-20210203","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1349-7006.2004.tb03211.x","article-title":"Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer","volume":"95","author":"Shimizu","year":"2004","journal-title":"Cancer Sci"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e3280147d13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:37:51Z","timestamp":1786034271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200706000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e3280147d13","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}